Your session is about to expire
← Back to Search
Hypertension telemedicine curriculum for High Blood Pressure
Study Summary
This trial will test a health education curriculum delivered by Weill Cornell Medicine faculty, medical students, and NY-Presbyterian Hospital resident physicians to adults in an under-resourced community.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have severe kidney disease and are undergoing hemodialysis treatment.
- Group 1: Hypertension telemedicine curriculum
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being monitored as part of this clinical research?
"Affirmative. Clinicaltrials.gov reveals that, since it was initially uploaded on October 4th 2021, this trial has been actively recruiting participants across 1 medical centre for a total of 40 patients."
What are the hoped-for outcomes of this experiment?
"The clinical trial's primary endpoint evaluates the participants' satisfaction with their curriculum at 12 weeks. Secondary endpoints track changes in daily steps taken, as measured by a wrist pedometer, and systolic/diastolic blood pressure readings recorded using an automatic arm cuff. These measurements will be collected from baseline to week 12 of the study."
Are patients currently allowed to register for this trial?
"Affirmative. The listing on clinicaltrials.gov demonstrates that this research is actively accepting participants, with 40 required from one site. This trial was first posted on October 4th 2021 and the information was last updated November 18th 2022."
Share this study with friends
Copy Link
Messenger